New directions in head and neck imaging

Journal of Surgical Oncology

Volumn 97, Issue 8, 2008, Pages 644-648

  Shah, Gaurang V ^a,b   Wesolowski, Jeffery R ^a   Ansari, Sameer A ^a   Mukherji, Suresh K ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

CT perfusion; F 18 FDG PET; Head and neck neoplasms, diagnosis; Magnetic resonance imaging

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

BONE METASTASIS; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CERVICAL LYMPH NODE; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LUNG METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

CONTRAST MEDIA; DIAGNOSTIC IMAGING; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; RADIOPHARMACEUTICALS;

EID: 44949187554     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21022     Document Type: Review

References (44)

1. Gatenby RA, Mulhern CB, Jr., Strawitz J, et al.: Comparison of clinical and computed tomographic staging of head and neck tumors. Am J Neuroradiol 1985;6:399-401.
2. Stark DD, Moss AA, Gamsu G, et al.: Magnetic resonance imaging of the neck. Part II. Pathologic findings. Radiology 1984;150:455-461.
3. Weber AL, Romo L, Hashmi S: Malignant tumors of the oral cavity and oropharynx: Clinical, pathologic and radiologic evaluation. Neuroimag Clin N Am 2003;13:443-464.
4. Wippold FJ: Head and Neck Imaging: The role of CT and MRI. J Magn Reson Imaging 2007;25:453-465.
5. McCabe KJ, Rubinstein D: Advances in head and neck imaging. Otolaryngologic Clin N Am 2005;38:307-319.
6. Yousem DM: Dashed hopes for MR imaging of the head and neck: The power of the needle. Radiology 1992;184:25-26.
7. Laubenbacher C, Saumweber D, Wagner-Manslau C: Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1992;36:1747-1757.
8. Schaefer PW, Copen WA, Lev MH, et al.: Diffusion-weighted imaging in acute stroke. Magn Reson Imaging Clin N Am 2006;14:141-168.
9. Wang J, Takashima S, Takayama F, et al.: Head and neck lesions: Characterization with diffusion-weighted echo-planar MR imaging. Radiology 2001;220:621-630.
10. Hermans R, Vandecaveye V: Diffusion-weighted MRI in head and neck cancer. Cancer Imaging 2007;7:126-127.
11. Abdel Razek AA, Kandeel AY, Soliman N, et al.: Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. Am J Neuroradiol 2007;28:1146-1152.
12. Abdel Razek AA, Soliman NY, Elkhamary S, et al.: Role of diffusion weighted MR imaging in cervical lymphadenopathy. Eur Radiol 2006;16:1468-1477.
13. Sumi M, Sakihama N, Sumi T, et al.: Discrimination of metastatic cervical lymph nodes with diffusion-weighted MR imaging in patients with head and neck cancer. Am J Neuroradiol 2003;79:681-687.
14. Lichy MP, Aschoff P, Plathow C, et al.: Tumor detection by diffusion-weighted MRI and ACD-mapping-initial clinical experiences in comparison to PET-CT. Invest Radiol 2007;42:605-613.
15. Schaefer PW, Ozsunar Y, He J, et al.: Assessing tissue viability with MR diffusion and perfusion imaging. Am J Neuroradiol 2003;24:436-443.
16. Gandhi D, Hoeffner EG, Carlos RC, et al.: Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract. Initial results. J Comput Assist Tomogr 2003;27:687-693.
17. Zima A, Carlos R, Gandhi D, et al.: Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy? Am J Neuroradiol 2007;28:328-334.
18. Bisdas S, Baghi M, Smolarz A, et al.: Quantitative measurements of perfusion and permeability of oropharyngeal and oral cavity cancer, recurrent disease, and associated lymph nodes using first-pass contrast-enhanced computed tomography studies. Invest Radiol 2007;42:172-179.
19. Schmitt P, Kotas M, Tobermann A, et al.: Quantitative tissue perfusion measurements in head and neck carcinoma patients before and during radiation therapy with a non-invasive MR imaging spin-labeling technique. Radiother Oncol 2003;67:27-34.
20. Paulus P, Sambon A, Vivegnis D, et al.: 18FDG-PET for the assessment of primary head and neck tumors: Clinical, computed tomography, and histopathological correlation in 38 patients. Laryngoscope 1998;108:1578-1583.
21. Schmid DT, Stoeckli SJ, Bandhauer F, et al.: Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck. Laryngoscope 2003;113:888-891.
22. Ng SH, Yen TC, Chang JT, et al.: Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck. J Clin Oncol 2006;24:4371-4376.
23. Mukherji SK, Bradford CR: Controversies: Is there a role for positron-emission tomographic CT in the initial staging of head and neck squamous cell carcinoma? Am J Neuroradiol 2006;27:243-245.
24. Di Martino E, Nowak B, Hassan HA, et al.: Diagnosis and staging of head and neck cancer: A comparison of modern imaging modalities (positron emission tomography, computed tomography, color-coded duplex sonography) with panendoscopic and histopathologic findings. Arch Otolaryngol Head Neck Surg 2000;126:1457-1461.
25. Benchaou M, Lehmann W, Slosman DO, et al.: The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer. Acta Otolaryngol 1996;116:332-335.
26. Schwartz DL, Rajendran J, Yueh B, et al.: FDG-PET prediction of head and neck squamous cell cancer outcomes. Arch Otolaryngol Head Neck Surg 2004;130:1361-1367.
27. Mukherji SK, Drane WB, Mancuso AA, et al.: Occult primary tumors of the head and neck: Detection with 2-(F-18) fluoro-2-deoxy-D-glucose SPECT. Radiology 1996;199:761-766.
28. Kole AC, Nieweg OE, Pruim J, et al.: Detection of unknown occult primary tumors using positron emission tomography. Cancer 1998;82:1160-1166.
29. AAssar OS, Fischbein NJ, Caputo GR, et al.: Metastatic head and neck cancer: Role and usefulness of FDG PET in locating occult primary tumors. Radiology 1999;210:177-181.
30. Sheikholeslam-Zadeh R, Choufani G, Goldman S, et al.: Unknown primary detected by FDG-PET: A review of the present indications of FDG-PET in head and neck cancers. Acta Otorhinolaryngol Belg 2002;56:77-82.
31. Gutzeit A, Antoch G, Kuhl H, et al.: Unknown primary tumors: Detection with dual-modality PET/CT: Initial experience. Radiology 2005;234:227-234.
32. Lowe VJ, Dunphy FR, Varvares M, et al.: Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography. Head Neck 1997;19:666-674.
33. Brasch RC: New directions in the development of MR imaging contrast media. Radiology 1992;183:1-11.
34. Kormano M, Dean PB: Extravascular contrast material: The major component of contrast enhancement. Radiology 1976;121:379-382.
35. Taylor JS, Tofts PS, Port R, et al.: MR imaging of tumor microcirculation: Promise for the new millennium. J Magn Reson Imaging 1999;10:903-907.
36. Padhani AR: Dynamic contrast-enhanced MRI in clinical oncology: Current status and future directions. J Magn Reson Imaging 2002;16:407-422.
37. Matsubayashi R, Matsuo Y, Edakuni G, et al.: Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: Correlation of MR findings with histologic features and expression of growth factors. Radiology 2000;217:841-848.
38. Sorensen AG, Tievsky AL, Ostergaard L, et al.: Contrast agents in functional MR imaging. J Magn Reson Imaging 1997;7:47-55.
39. Escott EJ, Rao VM, Ko WD, et al.: Comparison of dynamic contrast-enhanced gradient-echo and spin-echo sequences in MR of head and neck neoplasms. Am J Neuroradiol 1997;18:1411-1419.
40. Baba Y, Yamashita Y, Onomichi M, et al.: Dynamic magnetic resonance imaging of head and neck lesions. Top Magn Reson Imaging 1999;10:125-129.
41. Baba Y, Furusawa M, Murakami R, et al.: Role of dynamic MRI in the evaluation of head and neck cancers treated with radiation therapy. Int J Radiat Oncol Biol Phys 1997;37:783-787.
42. Guckel C, Schnabel K, Deimling M, et al.: Dynamic snapshot gradient-echo imaging of head and neck malignancies: Time dependency and quality of contrast-to-noise ratio. MAGMA 1996;4:61-69.
43. Hoskin PJ, Saunders MI, Goodchild K, et al.: Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. Br J Radiol 1999;72:1093-1098.
44. Yousem DM: Dynamic MR imaging of the head and neck: An idea whose time has come. . .and gone? Radiology 1993;189:659-660.